Summary of Purpose
To investigate the effects of an ACE inhibitor (ramipril) and vitamin E on atherosclerotic progression in high-risk patients.Read More →
The following dates are available for this trial. Trial information last updated on 19 June 2002.
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Medical Research Council of Canada, Hoechst-Marion Roussel
A substudy of the HOPE trial, this was a prospective, double-blind, 3 X 2 factorial trial.